Currently, GATA-binding protein 3 (GATA3), gross cystic disease fluid protein 15 (GCDFP-15), and mammaglobin are commonly used breast cancer-specific IHC markers in clinical practice [5]. This evidence concerns the gene GATA3 and breast cancer.